Tamura T, Ohmori K
Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Ltd., Sunto, Shizuoka, Japan.
Jpn J Pharmacol. 2001 Jan;85(1):101-4. doi: 10.1254/jjp.85.101.
Diacerein has proved to be effective in the treatment of osteoarthritis. We investigated the effects of rhein, an active metabolite of diacerein, on the degradation of recombinant human interleukin-1alpha (rhIL-1alpha)-induced proteoglycan and matrix metalloproteinases (MMPs) release from rabbit articular chondrocytes. Chondrocytes were treated for 24 h with rhein in the presence of rhIL-1alpha. Rhein suppressed the rhIL-1alpha-induced proteoglycan degradation. In addition, rhein decreased the rhIL-1alpha-induced proMMP-3 production and reduced the MMPs activity. These results suggested that diacerein might have a protective effect on proteoglycan degradation via the suppressive effect of rhein on the production of proMMPs.
双醋瑞因已被证明对骨关节炎的治疗有效。我们研究了双醋瑞因的活性代谢产物大黄酸对重组人白细胞介素-1α(rhIL-1α)诱导的蛋白聚糖降解以及兔关节软骨细胞中基质金属蛋白酶(MMPs)释放的影响。在存在rhIL-1α的情况下,用大黄酸处理软骨细胞24小时。大黄酸抑制了rhIL-1α诱导的蛋白聚糖降解。此外,大黄酸降低了rhIL-1α诱导的前MMP-3产生,并降低了MMPs的活性。这些结果表明,双醋瑞因可能通过大黄酸对前MMPs产生的抑制作用,对蛋白聚糖降解具有保护作用。